Avaxmed
Develops solid-dose vaccine and medication manufacturing and needle-free delivery technology for human and veterinary use
Highlights
- New on EvolcAdded 2026-10-28
About Avaxmed
aVaxMed develops manufacturing and delivery technology for solid-dose vaccines and medications. Its products include reusable and single-use delivery pens and a delivery system for veterinary products.
The technology is intended for human and animal healthcare. The company was founded in 2017 and is headquartered in Abingdon, UK.
Product: Solid-dose vaccine and medication manufacturing technology and needle-free delivery pens for human and veterinary use.
Jobs at Avaxmed
No open positions listed right now.
More biotech & pharma companies
Aviadobio
Gene therapies for people with neurodegenerative diseases, including FTD, retinal dystrophies, tauopathies and ALSNew on EvolcBasecamp Research
AI models and therapeutic pipeline built on evolutionary genomic data, with partnerships with pharma and biotech companiesSalary transparentBicycle Therapeutics
Develops precision-guided therapeutics for cancer and other diseases using Bicycle moleculesNew on EvolcRemote-friendlyBiocaptiva
CfDNA capture polymers and a whole-blood extraction kit for labs working on liquid biopsy and personalised medicineNew on EvolcBiomodal
Sequencing kits that read genetic variants and methylation from the same DNA sample for life science researchersNew on EvolcBiorelate
Literature-mined cause-and-effect data linking drugs, genes and diseases, for drug discovery and bioinformatics teamsNew on EvolcRemote-friendly
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- WordPress
- jQuery